# Jiangxi Synergy Pharmaceutical, Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5

> Inspection records and compliance data for Jiangxi Synergy Pharmaceutical, Co., Ltd. in Yichun, None. Access full analysis and detailed observations.

---

## Details

- Name: Jiangxi Synergy Pharmaceutical, Co., Ltd.
- FEI Number: 3008465739
- City: Yichun
- State: None
- Country Name: China
- Address Line 1: Jiangxi Fengxin Industrial Park, 699 Changle Avenue
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1280670 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2025-08-07](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/3510d974-c11b-4e77-8a55-41055a250a28) — source: FDA, date: August 7, 2025
- [FDA Inspection 1280670 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2025-08-07](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/7c7ba0ec-52be-431b-9d4f-87e4436eaee3) — classification: No Action Indicated (NAI), source: FDA, date: August 7, 2025
- [483 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2019-01-10](https://www.keypedia.com/records/483/jiangxi-synergy-pharmaceutical-co-ltd/593f05b9-a0ab-4103-adf1-cf723591f6e9) — source: FDA, date: January 10, 2019
- [FDA Inspection 1078075 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2019-01-10](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/860afe5f-1f7c-4561-9a5d-fb6d947ffb81) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 10, 2019
- [FDA Inspection 996538 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2016-09-09](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/b8e66a8e-136e-49ea-ac40-542f530683f8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 9, 2016
- [FDA Inspection 881487 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2014-05-09](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/a900fd7b-31f3-4688-a6d9-c2647cf4adc0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2014
- [FDA Inspection 614643 - Jiangxi Synergy Pharmaceutical, Co., Ltd. - 2009-09-11](https://www.keypedia.com/records/fda_inspections/jiangxi-synergy-pharmaceutical-co-ltd/bf561fc6-636e-4543-b625-bfb671b1bb46) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2009

## Related Companies

- [Strem Chemicals, Inc.](https://www.keypedia.com/companies/strem-chemicals-inc/285a934f-0fb3-4204-8233-4b3fc4364d64)
- [ISP Chemicals LLC](https://www.keypedia.com/companies/isp-chemicals-llc/8523c955-e979-40c7-afae-92f881ffe0d0)
- [Huber Soda, LLC](https://www.keypedia.com/companies/huber-soda-llc/89d2a595-ba2c-46a2-987c-65bb21b1b75b)
- [Calyx Chemicals & Pharmaceuticals Limited](https://www.keypedia.com/companies/calyx-chemicals-pharmaceuticals-limited/e01c292e-7fb4-4afa-b74e-c1afc698d94d)
- [Albemarle US, Inc.](https://www.keypedia.com/companies/albemarle-us-inc/336600a7-808b-4d7d-bfc0-7a9e728aa0aa)
- [HEC Pharm Co., Ltd.](https://www.keypedia.com/companies/hec-pharm-co-ltd/23b5826b-1111-4f49-a0ff-3b8731995caf)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Guangzhou Hanpu Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/guangzhou-hanpu-pharmaceutical-co-ltd/aa9e3246-019e-49cc-b473-391a75a82fd2)
- [BCN Peptides SA](https://www.keypedia.com/companies/bcn-peptides-sa/b0fa0b1d-5597-4653-9d34-ae9ab14d2de3)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)

## Related Officers

- [Senior CSO, Investigator](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)